Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence.
Ontology highlight
ABSTRACT: The COVID-19 pandemic has encouraged the repurposing of existing drugs as a shorter development strategy in order to support clinicians with this difficult therapeutic dilemma. There is evidence to support the theory that some antidepressants can reduce concentrations of different cytokines in humans and animals and, recently, the antiviral activity of some antidepressants against SARS-CoV-2 has been reported. The aims of this narrative review are to evaluate the possible role of antidepressants in the treatment of COVID-19 infection and the possible benefits and risks of patients taking antidepressants for mental disorders and COVID-19 infection. A review was performed to analyse the current literature to identify the role of antidepressant medication in the treatment of COVID-19 patients
SUBMITTER: Mas M
PROVIDER: S-EPMC9319396 | biostudies-literature | 2022 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA